Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RUFY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LINC01004 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
VAPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LHX6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FREM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4G3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UPP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GKAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLX4IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C6orf163 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTNNA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNAPC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLK12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO18B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VPS72 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL4D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TEF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on